Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
TLR4 links innate immunity and fatty acid-induced insulin resistance
Product Quality: The efficacy of a GHK-Cu product can vary significantly based on its synthesis quality, formulation vehicle, pH, packaging, and storage
SDP has received research funding from AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals Co., and Merck Sharpe & Dohme, and is a consultant for or has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Laboratoires Servier, Merck Sharp & Dohme, Novartis Pharmaceuticals Co., Novo Nordisk, Sanofi, and Takeda